| Dr Carol Angela Kiser, PHARM D | |
|
118 Se 9th St, Hy-vee, Pella, IA 50219-2200 | |
| (641) 628-1280 | |
| (641) 628-3625 |
| Full Name | Dr Carol Angela Kiser |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 118 Se 9th St, Pella, Iowa |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245440270 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 19791 (Iowa) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Carol Angela Kiser, PHARM D 132 Timber Ridge Dr, Pella, IA 50219-7847 Ph: (641) 625-1185 | Dr Carol Angela Kiser, PHARM D 118 Se 9th St, Hy-vee, Pella, IA 50219-2200 Ph: (641) 628-1280 |
News Archive
According to the French surgeons who carried out the world's first face transplant, six months down the line the operation is regarded as a complete success.
Genetic Technologies Limited, through its North American division, Phenogen Sciences Inc., has launched the new BREVAGen genetic test for assessing non-familial breast cancer risk.
Genentech, Inc. and Roche have announced that the New England Journal of Medicine published the first Phase III study of an anti-angiogenesis cancer therapy, showing that the addition of Avastin™ (bevacizumab) to the IFL chemotherapy regimen (5-FU/Leucovorin/ CPT-11) significantly extended survival in patients with first-line (previously untreated) metastatic colorectal cancer.
A working group of virologists headed by Professor Hans-Georg Kräusslich at Heidelberg University Hospitals, jointly with Professor Hanswalter Zentgraf, Division of Applied Tumor Virology of the Deutsches Krebsforschungszentrum (German Cancer Research Center, DKFZ), have been the first to label Human Immunodeficiency Viruses (HIV) for visual investigations without inhibiting the functional characteristics of the virus.
Researchers from the Smiley lab at the Trudeau Institute have now identified a single component of the plague causing bacterium that can be used as a vaccine. This single "subunit" could potentially be used to create a safer form of a T cell-stimulating plague vaccine. The new data is featured in the July issue of The Journal of Immunology.
› Verified 1 days ago
Allison Dop, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 405 Monroe St, Pella, IA 50219 Phone: 641-621-2444 Fax: 641-628-2164 | |
Mr. Joel Dean Shields, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1610 Vermeer Rd E, Pella, IA 50219 Phone: 641-621-7470 Fax: 641-621-7471 | |
Tiffany Druivenga, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1650 Washington St, Pella, IA 50219 Phone: 641-628-9227 | |
Joseph Phillip Formaro, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1610 Vermeer Rd E, Plant 3 & 1/2, Pella, IA 50219 Phone: 641-621-7470 Fax: 641-621-7471 | |
Mrs. Susan Kaye Strong, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 118 Se 9th St, Pella, IA 50219 Phone: 641-628-1280 Fax: 641-628-3626 | |
Mr. Thomas Bernard Vander Linden, RPH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 118 Se 9th St, Pella, IA 50219 Phone: 641-628-1280 Fax: 641-628-3626 |